Amyotrophic Lateral Sclerosis Disease – Global Clinical Trials Review, H1 2020

Pages: 304 Published: May 30, 2020 Report Code: GDHC6219CTIDB

GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2020" provides an overview of Amyotrophic Lateral Sclerosi Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyotrophic Lateral Sclerosi. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment

– Helps in identifying prominent locations for conducting clinical trials which saves time and cost

– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

– Supports understanding of trials count and enrollment trends by country in global therapeutics market

– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Key Players

  • Mitsubishi Chemical Holdings Corp

    Cytokinetics Inc

    Biogen Inc

    F. Hoffmann-La Roche Ltd

    Knopp Biosciences LLC

    GlaxoSmithKline Plc

    Teva Pharmaceutical Industries Ltd

    AB Science SA

    Newron Pharmaceuticals SpA

    Portage Biotech Inc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Amyotrophic Lateral Sclerosis to Central Nervous System Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Amyotrophic Lateral Sclerosis to Central Nervous System Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 26

In Progress Trials by Phase 27

Clinical Trials by Trial Status 28

Clinical Trials by End Point Status 30

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials 35

Prominent Drugs 37

Latest Clinical Trials News on Amyotrophic Lateral Sclerosis 38

Feb 28, 2020: Cytokinetics joins global initiative to recognize International Rare Disease Day 38

Clinical Trial Profile Snapshots 39

Appendix 300

Abbreviations 300

Definitions 300

Research Methodology 301

Secondary Research 301

About GlobalData 302

Contact Us 302

Source 303

List of Tables

List of Tables

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials by Region, 2020* 8

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 10

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 12

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 13

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, North America, Top Countries, 2020* 14

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020* 15

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 16

Proportion of Amyotrophic Lateral Sclerosis to Central Nervous System Clinical Trials, G7 Countries (%), 2020* 18

Amyotrophic Lateral Sclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 19

Amyotrophic Lateral Sclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 21

Proportion of Amyotrophic Lateral Sclerosis to Central Nervous System Clinical Trials, E7 Countries (%), 2020* 23

Amyotrophic Lateral Sclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 24

Amyotrophic Lateral Sclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 26

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials by Phase, 2020* 27

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 28

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2020* 30

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2020* 31

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 32

Amyotrophic Lateral Sclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 33

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 35

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 37

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 38

List of Figures

List of Figures

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials by Region (%), 2020* 8

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020* 12

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020* 13

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2020* 14

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020* 15

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020* 16

Proportion of Amyotrophic Lateral Sclerosis to Central Nervous System Clinical Trials, G7 Countries (%), 2020* 17

Amyotrophic Lateral Sclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 19

Amyotrophic Lateral Sclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 20

Proportion of Amyotrophic Lateral Sclerosis to Central Nervous System Clinical Trials, E7 Countries (%), 2020* 22

Amyotrophic Lateral Sclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 24

Amyotrophic Lateral Sclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 25

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2020* 27

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2020* 28

Amyotrophic Lateral Sclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2020* 29

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2020* 31

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 32

Amyotrophic Lateral Sclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020* 33

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 34

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 36

Amyotrophic Lateral Sclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 38

GlobalData Methodology 302

Frequently Asked Questions

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.